Management of Women With BRCA1/2 Mutation

Status Completed

Clinical Trial Summary

The aim of this study is to determine general practitionners' role in management of women with BRCA1/2 mutation.

This study will be conduct between April 2017 and December 2017 at Montpellier University Hospital on women followed-up in the department of genetics and their general practitionners (GP). Patients and their GP will be called by the investigators and questionnaire will be given to them. Questionnaire includes questions for patients and their GP. The primary endpoint was to determine the rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation. Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions. Secondary endpoint was to determine women' opinion on their GP : whether or not well managed for their BRCA 1 / 2 mutation.

Clinical Trial Description

PURPOSE: The aim of this study is to determine general practitionners' role in management of women with BRCA1/2 mutation.

METHODS:

This study will be conduct between April 2017 and December 2017 at Montpellier University Hospital on women followed-up in the department of genetics and their general practitionners (GP). Patients and their GP will be called by the investigators and questionnaire will be given to them. Questionnaire includes questions for patients and their GP. The primary endpoint was to determine the rate of GP having sufficient knowledge of the adequate management of patients with BRCA1 / 2 mutation. Adequate knowledge includes : systematic search for a family history of cancer, knowing criteria required to refer women in oncogenetic department, and the ability to respond to patients' questions. Secondary endpoint was to determine women' opinion on their GP : whether or not well managed for their BRCA 1 / 2 mutation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03211611
Study type	Observational
Source	University Hospital, Montpellier
Contact
Status	Completed
Phase
Start date	April 1, 2017
Completion date	November 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04890327` - Web-based Family History Tool	N/A
Withdrawn	`NCT03032614` - Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients	Phase 2
Not yet recruiting	`NCT04055038` - Efficacy of Platinum-based Chemotherapy in Platinum-resistant Ovarian Cancer) (EPITOC)	Phase 2/Phase 3
Recruiting	`NCT04566952` - Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer	Phase 2
Recruiting	`NCT04499534` - BRCA1/2 Flu Vaccine
Recruiting	`NCT05537844` - Longitudinal Sample Collection to Investigate Adaptation and Evolution of Ovarian High-grade Serous Carcinoma
Active, not recruiting	`NCT03685331` - HOPE: Olaparib, Palbociclib and Fulvestrant in Patients With BRCA Mutation-associated, HR+, HER2-metastatic Breast Cancer	Phase 1
Recruiting	`NCT05097274` - The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a BRCA Gene Mutation.
Completed	`NCT03428399` - Depression and Body Image Distress Following Mastectomy With Reconstruction
Completed	`NCT02957981` - The Genetic Education for Men Trial: Web-Based Education vs. Standard Care	N/A
Recruiting	`NCT04556071` - Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer	Phase 2
Completed	`NCT04651920` - A Study on Association Between HR Genes and the HRD Status in Chinese Epithelial Ovarian Cancer
Completed	`NCT02974842` - Pre-Salpingo-Oophorectomy Pilot Study of MAKO 7 Device Performance
Active, not recruiting	`NCT03351803` - BRCA Founder OutReach (BFOR) Study
Withdrawn	`NCT05062174` - Breast Cancer BRCA1 Carriers: a Pilot Study
Suspended	`NCT04151368` - Surgical and Patient Reported Outcomes of Robotic Nipple-Sparing Mastectomy	N/A
Active, not recruiting	`NCT04273542` - Interest of Broadband Spectroscopy Analysis by Infrared Laser on Liquid Biopsies in Breast Cancer Screening	N/A
Recruiting	`NCT05694715` - Combination Therapy in Cancers With Mutations in DNA Repair Genes	Phase 1
Recruiting	`NCT06395519` - A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies	Phase 1
Recruiting	`NCT05410951` - LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients